{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:03:13Z","timestamp":1781802193348,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jim.2014.01.011","type":"journal-article","created":{"date-parts":[[2014,1,25]],"date-time":"2014-01-25T12:14:22Z","timestamp":1390652062000},"page":"87-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["A specific assay for quantification of human C4c by use of an anti-C4c monoclonal antibody"],"prefix":"10.1016","volume":"405","author":[{"given":"Katrine","family":"Pilely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel-Ole","family":"Skjoedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Emil","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Louise Aabom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Vitved","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Skj\u00f8dt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaseelan","family":"Palarasah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2014.01.011_bb0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1254\/jjp.35.203","article-title":"Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments","volume":"35","author":"Aoyama","year":"1984","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.jim.2014.01.011_bb0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.molimm.2013.05.221","article-title":"An international serum standard for application in assays to detect human complement activation products","volume":"56","author":"Bergseth","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2014.01.011_bb0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0022-1759(81)90107-1","article-title":"Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma","volume":"44","author":"Brandslund","year":"1981","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2014.01.011_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0065-2776(08)60340-5","article-title":"The classical complement pathway: activation and regulation of the first complement component","volume":"37","author":"Cooper","year":"1985","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.jim.2014.01.011_bb0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/elps.1150070807","article-title":"Immunoblotting analysis of the peptide-chain structure of the physiological breakdown products of the 3rd component of human-complement","volume":"7","author":"Folkersen","year":"1986","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jim.2014.01.011_bb0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0091-6749(92)90367-B","article-title":"Detection of complement in relation to disease","volume":"89","author":"Frank","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jim.2014.01.011_bb0035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0005-2744(81)90023-1","article-title":"New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin","volume":"661","author":"Fujii","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jim.2014.01.011_bb0040","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-3083.1997.d01-168.x","article-title":"A neoepitope-based enzyme immunoassay for quantification of C1-inhibitor in complex with C1r and C1s","volume":"46","author":"Fure","year":"1997","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jim.2014.01.011_bb0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3083.1988.tb02354.x","article-title":"Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3","volume":"27","author":"Garred","year":"1988","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jim.2014.01.011_bb0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0162-3109(00)80302-1","article-title":"Complement components of the innate immune system in health and disease in the CNS","volume":"49","author":"Gasque","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jim.2014.01.011_bb0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-9343(89)90224-6","article-title":"Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis","volume":"86","author":"Hack","year":"1989","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jim.2014.01.011_bb0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0022-1759(87)90134-7","article-title":"Sensitive ELISA for quantitating the terminal membrane C5b-9 and fluid-phase SC5b-9 complex of human complement","volume":"99","author":"Hugo","year":"1987","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2014.01.011_bb0065","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1177\/1352458512438238","article-title":"Systemic complement profiling in multiple sclerosis as a biomarker of disease state","volume":"18","author":"Ingram","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jim.2014.01.011_bb0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"Kohler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.jim.2014.01.011_bb0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/pro.5560060201","article-title":"The internal thioester and the covalent binding properties of the complement proteins C3 and C4","volume":"6","author":"Law","year":"1997","journal-title":"Protein Sci."},{"key":"10.1016\/j.jim.2014.01.011_bb0080","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1016\/j.molimm.2007.06.006","article-title":"The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies","volume":"44","author":"Li","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jim.2014.01.011_bb0085","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000345356","article-title":"Collectin-11\/MASP complex formation triggers activation of the lectin complement pathway\u2014the fifth lectin pathway initiation complex","volume":"5","author":"Ma","year":"2013","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.jim.2014.01.011_bb0090","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1111\/j.1582-4934.2008.00504.x","article-title":"Complexity of complement activation in sepsis","volume":"12","author":"Markiewski","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jim.2014.01.011_bb0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00005-013-0229-y","article-title":"Structural and functional overview of the lectin complement pathway: its molecular basis and physiological implication","volume":"61","author":"Matsushita","year":"2013","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.jim.2014.01.011_bb0100","first-page":"131","article-title":"Three cases of factor I deficiency: the effect of treatment with plasma","volume":"74","author":"Moller Rasmussen","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2014.01.011_bb0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-3083.1985.tb01871.x","article-title":"Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex","volume":"22","author":"Mollnes","year":"1985","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jim.2014.01.011_bb0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2249.1993.tb05898.x","article-title":"Complement activation in septic baboons detected by neoepitope-specific assays for C3b\/iC3b\/C3c, C5a and the terminal C5b-9 complement complex (TCC)","volume":"91","author":"Mollnes","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2014.01.011_bb0115","doi-asserted-by":"crossref","first-page":"578","DOI":"10.4049\/jimmunol.125.2.578","article-title":"Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator","volume":"125","author":"Nagasawa","year":"1980","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2014.01.011_bb0120","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1349-7006.2008.01055.x","article-title":"Large-scale quantitative clinical proteomics by label-free liquid chromatography and mass spectrometry","volume":"100","author":"Negishi","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jim.2014.01.011_bb0125","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/07853890701477546","article-title":"Rheumatoid arthritis and the complement system","volume":"39","author":"Okroj","year":"2007","journal-title":"Ann. Med."},{"key":"10.1016\/j.jim.2014.01.011_bb0130","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2249.2011.04322.x","article-title":"Novel assays to assess the functional capacity of the classical, the alternative and the lectin pathways of the complement system","volume":"164","author":"Palarasah","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2014.01.011_bb0135","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jim.2010.09.024","article-title":"Generation of a C3c specific monoclonal antibody and assessment of C3c as a putative inflammatory marker derived from complement factor C3","volume":"362","author":"Palarasah","year":"2010","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2014.01.011_bb0140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF01893019","article-title":"The alternative pathway of complement","volume":"7","author":"Pangburn","year":"1984","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.jim.2014.01.011_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-2427(02)00231-3","article-title":"Haemolytic complement activity, C3 and Factor B consumption in serum from chickens divergently selected for antibody responses to sheep red blood cells","volume":"90","author":"Parmentier","year":"2002","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.jim.2014.01.011_bb0150","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/clinchem\/45.8.1190","article-title":"Possible mechanism for in vitro complement activation in blood and plasma samples: futhan\/EDTA controls in vitro complement activation","volume":"45","author":"Pfeifer","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jim.2014.01.011_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(87)90098-6","article-title":"Immunoaffinity chromatography utilizing monoclonal antibodies. Factors which influence antigen-binding capacity","volume":"97","author":"Pfeiffer","year":"1987","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2014.01.011_bb0160","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-3083.1986.tb02008.x","article-title":"A family with complement factor I deficiency","volume":"23","author":"Rasmussen","year":"1986","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jim.2014.01.011_bb0165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2009.10.019","article-title":"Serum levels of complement C4 fragments correlate with disease activity in multiple sclerosis: proteomic analysis","volume":"218","author":"Sawai","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jim.2014.01.011_bb0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jim.2004.11.016","article-title":"Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA","volume":"296","author":"Seelen","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2014.01.011_bb0175","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jim.2011.10.010","article-title":"An enzyme-linked immunosorbent assay (ELISA) for quantification of human collectin 11 (CL-11, CL-K1)","volume":"375","author":"Selman","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2014.01.011_bb0180","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/386506a0","article-title":"A second serine protease associated with mannan-binding lectin that activates complement","volume":"386","author":"Thiel","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jim.2014.01.011_bb0185","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2014.01.011_bb0190","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.jim.2014.01.011_bb0195","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1186\/ar586","article-title":"Complement and systemic lupus erythematosus","volume":"4","author":"Walport","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.jim.2014.01.011_bb0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0022-1759(93)90240-8","article-title":"Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway","volume":"163","author":"Wolbink","year":"1993","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2014.01.011_bb0205","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.4049\/jimmunol.171.5.2734","article-title":"Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index","volume":"171","author":"Yang","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2014.01.011_bb0210","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1523-1755.2001.0590041227.x","article-title":"Intrarenal synthesis of complement","volume":"59","author":"Zhou","year":"2001","journal-title":"Kidney Int."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217591400026X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217591400026X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T01:57:46Z","timestamp":1688954266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002217591400026X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":42,"alternative-id":["S002217591400026X"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2014.01.011","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A specific assay for quantification of human C4c by use of an anti-C4c monoclonal antibody","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2014.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}